Is Amrutanjan Health Care Ltd (AMRUTANJAN) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Amrutanjan Health Care Ltd is a good quality company .

Is Amrutanjan Health Care Ltd (AMRUTANJAN) undervalued or overvalued?

The key valuation ratios of Amrutanjan Health Care Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Amrutanjan Health Care Ltd (AMRUTANJAN) share price return in the past 10 years?

Amrutanjan Health Care Ltd share price has appreciated 9.6% annually (CAGR) over the past ten years.

Is Amrutanjan Health Care Ltd (AMRUTANJAN) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Amrutanjan Health Care Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Amrutanjan Health Care Ltd (AMRUTANJAN)?

Company share prices are keep on changing according to the market conditions. The current trading price of Amrutanjan Health Care Ltd (AMRUTANJAN) on 17-Apr-2026 16:59:59 at 16:59 is 546.50.

What is the market cap of Amrutanjan Health Care Ltd (AMRUTANJAN)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 17-Apr-2026 at 16:59, the market cap of Amrutanjan Health Care stood at Rs. 1579.97 Cr.

What is the P/E ratio of Amrutanjan Health Care?

The latest standalone P/E ratio of Amrutanjan Health Care as of 17-Apr-2026 is 27.77.

What is the P/B ratio of Amrutanjan Health Care Ltd (AMRUTANJAN)?

The latest standalone P/B ratio of Amrutanjan Health Care Ltd (AMRUTANJAN) as of 17-Apr-2026 is 4.37.

What is the 52-week high and low of Amrutanjan Health Care Ltd (AMRUTANJAN)?

The 52-week high of Amrutanjan Health Care Ltd (AMRUTANJAN) is Rs. 789.95 and the 52-week low is Rs. 490.00.

What is the TTM revenue of Amrutanjan Health Care Ltd (AMRUTANJAN)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amrutanjan Health Care is Rs. 488.20 (Cr.).

Amrutanjan Health Care Ltd (AMRUTANJAN) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Amrutanjan Health Care Ltd (AMRUTANJAN)
Brand: Amrutanjan Health Care

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	30.9%	28.7%	27%	25.4%	22.8%	44%	37.9%	19.4%	21.5%	22.6%	-
Value Creation Index ⓘ	1.2	1.1	0.9	0.8	0.6	2.1	1.7	0.4	0.5	0.6	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	184	212	220	253	261	333	406	380	421	452	488
Sales YoY Gr.	-	14.8%	4%	15.2%	3.2%	27.3%	21.9%	-6.5%	11%	7.3%	-
Adj EPS ⓘ	7.5	7.5	6.4	8.4	8.6	20.9	23	13.6	15.5	17.6	19.7
YoY Gr.	-	0.3%	-14.9%	31.4%	2%	144.9%	9.8%	-40.8%	14.1%	13.2%	-
BVPS (₹) ⓘ	41.2	39.6	44	49.9	54.5	73.5	90.5	99.1	99.9	112.8	125.1
Adj Net Profit ⓘ	21.9	21.9	18.7	24.5	25	61.2	67.2	39.8	44.9	50.8	57
Cash Flow from Ops. ⓘ	21.4	8.3	19.1	21.2	18.2	90.9	52.2	20.2	27.9	50.9	-
Debt/CF from Ops. ⓘ	0	0.3	0	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	10.5%	11.6%	3.6%	7.3%
Adj EPS ⓘ	10%	15.5%	-8.6%	13.2%
BVPSⓘ	11.8%	15.7%	7.6%	12.9%
Share Price	9.6%	-2.2%	-3.8%	-19%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	19.4	18.6	15.3	17.9	16.4	32.7	28	14.3	15.5	16.5	16.6
Op. Profit Mgn % ⓘ	17.1	14.2	12.9	12.2	11.8	20.3	19.1	11.8	12.4	12.9	13.9
Net Profit Mgn % ⓘ	11.9	10.4	8.5	9.7	9.6	18.4	16.6	10.5	10.7	11.3	11.7
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	123	122	111	81	125	115	130	208	224	224	104
Cash Conv. Cycle ⓘ	43	24	12	14	19	-7	-12	0	6	5	75

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 16.50%

Sales growth is good in last 4 quarters at 10.22%

Sales growth has been subdued in last 3 years 3.64%

Net Profit has been subdued in last 3 years -8.55%

	Standalone	Consolidated
TTM EPS (₹)	19.7	7.3
TTM Sales (₹ Cr.)	488	232
BVPS (₹) ⓘ	125.1	0
Reserves (₹ Cr.) ⓘ	359	106
P/BV ⓘ	4.37	0.00
PE ⓘ	27.77	74.73

From the Market
52 Week Low / High (₹)	490.00 / 789.95
All Time Low / High (₹)	5.05 / 1025.55
Market Cap (₹ Cr.)	1,580
Equity (₹ Cr.)	2.9
Face Value (₹)	1
Industry PE ⓘ	42.1

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	184	212	220	253	261	333	406	380	421	452
Operating Expenses ⓘ +	153	182	192	222	231	266	328	335	369	394
Manufacturing Costs	37	7	17	16	17	18	29	34	35	35
Material Costs	37	87	96	119	117	140	180	182	212	223
Employee Cost	28	30	34	33	39	42	48	49	48	59
Other Costs ⓘ	51	57	45	54	57	66	71	71	75	76
Operating Profit ⓘ	32	30	28	31	31	67	78	45	52	58
Operating Profit Margin (%)	17.1%	14.1%	12.9%	12.2%	11.8%	20.2%	19.1%	11.7%	12.3%	12.9%
Other Income ⓘ +	6	7	8	7	8	19	17	15	16	18
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	1	0	0	0	1	1	0	0	0
Depreciation ⓘ	3	3	3	3	4	4	4	5	6	7
Profit Before Tax ⓘ	35	34	33	35	34	82	91	54	62	69
Tax ⓘ	12	12	13	10	9	21	23	14	17	18
Profit After Tax	22	22	20	25	25	61	67	40	45	51
PAT Margin (%)	12.2%	10.3%	9.1%	9.7%	9.6%	18.4%	16.6%	10.5%	10.7%	11.3%
Adjusted EPS (₹)	7.7	7.5	6.9	8.4	8.6	20.9	23.0	13.6	15.6	17.6
Dividend Payout Ratio (%)	25%	26%	28%	26%	24%	20%	20%	34%	30%	26%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	120	116	129	146	159	215	265	290	289	326
Share Capital ⓘ	3	3	3	3	3	3	3	3	3	3
Reserves ⓘ	118	113	126	143	157	212	262	287	286	323
Debt +	0	2	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	2	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	9	25	26	30	31	41	60	47	56	69
Others Liabilities ⓘ	19	5	7	8	10	15	21	21	19	23
Total Liabilities ⓘ	149	149	162	183	201	271	346	358	364	418
Fixed Assets
Net Fixed Assets ⓘ +	22	27	28	26	26	23	28	49	50	49
Gross Block	39	30	33	35	39	39	48	74	76	82
Accumulated Depreciation	16	3	6	9	13	16	19	25	26	32
CWIP ⓘ	1	1	0	0	0	2	17	1	2	16
Investments ⓘ	10	10	8	18	18	18	13	5	0	0
Inventories	8	10	10	15	24	17	26	29	29	27
Trade Receivables	26	29	28	33	26	18	38	33	48	56
Cash Equivalents	48	31	73	81	36	139	88	70	27	83
Others Assets ⓘ	34	42	16	11	70	54	136	170	208	186
Total Assets ⓘ	149	149	162	183	201	271	346	358	364	418

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	21	8	19	21	18	91	52	20	28	51
PBT ⓘ	35	34	33	35	34	82	91	54	62	69
Adjustment ⓘ	-2	-0	-4	-3	-1	-3	-10	-8	-7	-9
Changes in Working Capital ⓘ	1	-11	0	-1	-4	31	-4	-10	-10	9
Tax Paid ⓘ	-11	-14	-11	-10	-11	-19	-24	-16	-16	-18
Cash Flow From Investing Activity ⓘ +	1	-0	-8	-11	-14	-88	-36	-2	19	-31
Capex	-1	-4	-1	-2	-3	-2	-23	-9	-6	-36
Net Investments	0	-1	-13	-14	-17	-92	-25	-5	12	-11
Others ⓘ	3	4	6	5	6	6	13	11	14	16
Cash Flow From Financing Activity ⓘ +	-11	-5	-9	-7	-12	-7	-17	-15	-48	-13
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	1	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0	-1	-0	-0	-0	-0	0	0	0	0
Dividend Paid ⓘ	-11	-4	-6	-6	-9	-6	-12	-14	-13	-13
Others ⓘ	0	-0	-4	-1	-2	-2	-4	-1	-36	-0
Net Cash Flow ⓘ	12	3	2	3	-7	-4	-1	3	-1	6

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	19.9	18.46	16.41	17.87	16.44	32.69	28.03	14.37	15.54	16.53
ROCE (%)	30.86	28.65	26.95	25.43	22.8	44	37.93	19.38	21.47	22.58
Asset Turnover Ratio	1.39	1.49	1.42	1.47	1.36	1.41	1.32	1.08	1.17	1.16
PAT to CFO Conversion(x)	0.95	0.36	0.95	0.84	0.72	1.49	0.78	0.5	0.62	1
Working Capital Days
Receivable Days	50	45	47	44	41	24	25	34	35	42
Inventory Days	14	15	17	18	27	23	20	26	25	23
Payable Days	81	72	98	86	95	94	102	108	89	102

About Amrutanjan Health Care Ltd

Amrutanjan Health Care was started in the year 1893 by social reformer, journalist and freedom fighter, Nageswara Rao Pantulu Garu. Today Amrutanjan is one of the household names in South India.

While Amrutanjan Pain Balm (Yellow Balm) is the flagship brand of the company with a rich heritage of over 100 years, the company is also planning to introduce a series of next generation products in healthcare category.

With a wide range of ayurvedic and allopathic products, Amrutanjan has helped millions of people relieve themselves from the pain and discomfort of headaches, colds, sprains, muscular pains, rheumatic pains and stands a real pain management specialist for its loyal customers.

The company has diversified into various businesses in the health care segment like the Fine Chemical Division and Osmosys Medical Clinic located in Chennai. Apart from the products in the pain care segment, other categories include cough and cold care, health and home care.

Its products are available in the Gulf, African, South East and Asian countries. Plans are ready to enter the US and European markets in a big way.

Products

Amrutanjan pain balm
Dragon Roll-on liquid balm
Joint ache cream
Pain relief kit
Cold rub
Vaporising gel
Cough drops
Swas mint
Diakyur capsules
Jiffy tablets
Decorn (corn caps)
Cutis olive oil, etc.

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Amrutanjan Health Care Ltd (AMRUTANJAN) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Amrutanjan Healthcar Share Price